Lambda Biologics

Startseite
Deutschland
Leipzig
Lambda Biologics

Lambda Biologics is a hub for bio-health knowledge and research, offering an advanced testing platform.

Explore animal-free solutions and experience fast and accurate results with the enhanced services of MyLab.

09/06/2026

🔬 From cell lines to patients: where do organoids fit?

The KAIST colorectal cancer study showed how patient-derived can provide critical human-relevant validation in drug development.

The study showed that the repurposed drug candidate significantly suppressed the growth and viability of patient-derived CRC organoids while increasing autophagy.

This is also a case study that demonstrates how modern research benefits from an integrated approach:

✓ 2D cell models for mechanism studies
✓ CRC organoids for human-relevant validation
✓ PDX models for in vivo confirmation

Together, they create a stronger preclinical workflow than any single model alone.

Read more via the link in bio.

05/06/2026

𝐍𝐞𝐰 𝐏𝐮𝐛𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭

We're excited to share a recent publication demonstrating the potential of hair organoids as a next-generation platform for androgenic alopecia ( ) research and anti-hair loss efficacy testing.

The study highlights the utility of as a novel experimental model for evaluating AGA therapies. By overcoming key limitations of traditional in vitro systems, hair-bearing organoids provide a more physiologically relevant platform for assessing therapeutic and cosmetic candidates targeting androgenic alopecia.

As the demand for predictive, human-relevant, and animal-free testing models continues to grow, hair organoids are creating new opportunities to advance hair loss research and accelerate product development.

👉 Connect with us to learn more [Link in Bio]

03/06/2026

New treatment advances are reshaping the cancer landscape, from relacorilant combinations and immunotherapy strategies to antibody-drug conjugates ( ) such as Elahere® and TUB-040 (trial phase I).

As therapies become increasingly personalized, -derived ovarian are emerging as powerful tools for studying treatment response, resistance mechanisms, and precision oncology.

Read our latest blog to explore the latest clinical breakthroughs and the growing role of organoid technology in ovarian cancer research.

🔗 https://lnkd.in/gMEBxsWB

Contact us for the Ovarian Cancer research inquiry!

29/05/2026

🌍 World Digestive Health Day 2026 |

“Chronic Diarrhea: Don’t Flush the Signs Away.”

Digestive symptoms are often overlooked or left unspoken, despite being important signals of underlying gastrointestinal conditions such as IBD or IBS. This year’s World Digestive Health Day highlights the importance of awareness, early consultation, and breaking the stigma around digestive disorders.

At Lambda Biologics, we continue supporting digestive health research through human-relevant models with ODISEI Gut. By combining advanced organoid technologies with translational research, we aim to support more predictive, human-relevant approaches for digestive health research and therapeutic development.

🔬Contact Us: [Link in Bio]

28/05/2026

Welcome to Lambda's booth at the International MPS Society (iMPSS) 2026 🚀

Great conversations, new connections, and exciting discussions around technologies and human-relevant models for translational research.
At Booth #713, we’re showcasing how our functional organoid platforms support:
🔬 Disease modeling
🧬 Mechanism discovery
💊 Drug evaluation & validation
🧫 Immune interaction studies

It’s inspiring to meet researchers, biotech innovators, and industry partners who are driving the future of Microphysiological Systems (MPS).

Can’t visit the booth? Send us your inquiry (Link in Bio), and our team will respond within 24 hours to arrange an online discussion.

26/05/2026

The is more than a digestive organ - it is a critical interface where external substances interact with the human body, influencing health, disease, immunity, metabolism, and therapeutic response. By closely mimicking key intestinal structures and functions, ODISEI Gut provides a more predictive and human-relevant alternative to conventional in vitro systems for pharma, biotech, and functional food research.

Meet at MPS World Summit 2026 - Booth #713 to discuss ODISEI Gut, our advanced human platform for translational research and therapeutic development.

20/05/2026

Brain Cancer Awareness Month is a reminder of the urgent need for more predictive, human-relevant neuroscience models to understand complex diseases better and accelerate therapeutic discovery.

At Lambda Biologics, we are advancing hashtag -based Solutions designed to support translational research, disease modeling, and therapeutic evaluation through physiologically relevant 3D platforms.

🧠 Connect with us to learn about custom-built organoid models tailored to specific study designs, disease mechanisms, and therapeutic evaluation workflows.

14/05/2026

We’re excited to announce that Lambda Biologics will be exhibiting at the MPS World Summit 2026 - a global meeting advancing microphysiological systems (MPS) and engineered models that better replicate human biology.

At Booth 713, we will showcase our functional organoid platforms designed to support:
🧬 Disease modeling
🧫 Immune and microenvironment interaction studies
💊 Translational research & drug discovery
🔬 Functional phenotypic analysis

We look forward to connecting with researchers, partners, and innovators shaping the future of organoid and MPS research.

11/05/2026

The future of functional food innovation is deeply connected to the microbiome 🦠

Intestinal organoids are emerging as a powerful platform enabling microbiome researchers to study:
- Host–microbe interactions
- Microbial metabolite responses
- Epithelial barrier function
- Immune & inflammatory signaling
- Probiotic, prebiotic & postbiotic activity

Compared with conventional 2D systems, organoids provide a more human-relevant platform to study how functional food ingredients influence gut biology.

As precision nutrition continues to grow, intestinal organoids may become key tools for next-generation microbiome research. Let’s explore the future of microbiome-driven functional food innovation together.
🔗 Link in Bio!

hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag hashtag

07/05/2026

Cultured directly from patient tumor biopsies, our patient-derived organoids (PDOs) preserve the tumor’s genetic fidelity and phenotypic complexity. By overcoming the limitations of traditional 2D cell lines and animal models, Lambda’s PDOs provide highly clinically relevant platforms - enabling more accurate prediction of drug efficacy and patient response.

Our organoid biobank spans multiple cancer types, offering a diverse library to support robust drug screening and discovery. This resource accelerates decision-making across the R&D pipeline and helps identify promising candidates for a wide range of tumor profiles.

Contact us to explore how our PDO platforms can support your research.
🔗 Link in Bio!

--
Lambda Biologics - Unlocking Human Insight with Organoid Models

Adresse

Deutscher Platz. 5c
Leipzig
04103

Webseite

http://afs.lambda-bio.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Lambda Biologics erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.